Literature DB >> 1380464

Aortic features in Tangier disease and pathogenetic considerations--Part I. Fatty dots and streaks.

M D Haust1.   

Abstract

Morphological studies of aortic fatty dots and streaks, and the adjacent normally appearing intima, in a 5 3/4-year-old boy who died of pneumonia, showed several hitherto unreported features. In lesions, lipid vacuoles and/or other cytoplasmic "inclusions" (ultrastructurally considered to present complex forms of lipids) were present on occasion in the endothelium but consistently involved the (intimal) smooth muscle cells (SMC). Similar changes were present in the adjacent intima, but were here less prominent and "tapered off" distally. A moderate number of macrophages also contained cytoplasmic lipids but such cells entirely free of lipid inclusions were observed, too. Most surprisingly, dilated and many cisternae of rough-surfaced endoplasmic reticulum (ER) in the SMC of lesions were associated spatially with cytoplasmic droplets and other forms of lipids. The results of these studies question the generally accepted central role of macrophages as being primarily involved in the pathogenesis of tissue changes in Tangier disease. It is possible that in view of the absence or paucity of high-density lipoproteins (HDL) and alterations of (their) apo A-I and apo A-II (as well as of other lipids), the arterial SMC may be in some way involved in the metabolism of the above substances in this disorder. Support of this tentative (and highly speculative) assumption must await further work utilizing tissues and cells other than those containing macrophages and other derivatives of reticulo-endothelial system.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1380464     DOI: 10.1007/bf00145348

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  34 in total

1.  Binding of high density lipoproteins to cell receptors promotes translocation of cholesterol from intracellular membranes to the cell surface.

Authors:  J P Slotte; J F Oram; E L Bierman
Journal:  J Biol Chem       Date:  1987-09-25       Impact factor: 5.157

2.  Interaction of high density lipoprotein with its receptor on cultured fibroblasts and macrophages. Evidence for reversible binding at the cell surface without internalization.

Authors:  J F Oram; C J Johnson; T A Brown
Journal:  J Biol Chem       Date:  1987-02-15       Impact factor: 5.157

3.  Familial high-density lipoprotein deficiency (Tangier disease): the third Italian case.

Authors:  G Bracco; G Dotti; F Levis; E David; G Saracco; M Rizzetto; G Verme
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

4.  [Cardiologic aspects of a case of Tangier disease].

Authors:  A C Plancher; S Maccari; C Tramaloni; G Vigotti; G A Giudici
Journal:  G Clin Med       Date:  1984 Mar-Apr

5.  Ocular manifestations of familial high-density lipoprotein deficiency (Tangier disease).

Authors:  F C Chu; T Kuwabara; D G Cogan; E J Schaefer; H B Brewer
Journal:  Arch Ophthalmol       Date:  1979-10

6.  Interaction of high density lipoprotein with adipocytes in a new patient with Tangier disease.

Authors:  J Frohlich; B Fong; P Julien; J P Despres; A Angel; M Hayden; R McLeod; C Chow; R H Davison; H Pritchard
Journal:  Clin Invest Med       Date:  1987-09       Impact factor: 0.825

7.  [Familial analphalipoproteinemia (Tangier disease)].

Authors:  H Kummer; J Laissue; H Spiess; R Pflugshaupt; U Bucher
Journal:  Schweiz Med Wochenschr       Date:  1968-03-16

8.  Isolation and characterization of an apoA-II-containing lipoprotein (LP-A-II:B complex) from plasma very low density lipoproteins of patients with Tangier disease and type V hyperlipoproteinemia.

Authors:  P Alaupovic; C Knight-Gibson; C S Wang; D Downs; E Koren; H B Brewer; R E Gregg
Journal:  J Lipid Res       Date:  1991-01       Impact factor: 5.922

9.  Regulation of the selective uptake of high density lipoprotein-associated cholesteryl esters.

Authors:  F Rinninger; R C Pittman
Journal:  J Lipid Res       Date:  1987-11       Impact factor: 5.922

10.  Familial apolipoprotein A-I and C-III deficiency, variant II.

Authors:  E J Schaefer; J M Ordovas; S W Law; G Ghiselli; M L Kashyap; L S Srivastava; W H Heaton; J J Albers; W E Connor; F T Lindgren
Journal:  J Lipid Res       Date:  1985-09       Impact factor: 5.922

View more
  1 in total

1.  Acid sphingomyelinase deficiency: cardiac dysfunction and characteristic findings of the coronary arteries.

Authors:  H Ishii; T Takahashi; M Toyono; M Tamura; K Harada; M Yoshida; Y Nishikawa; K Enomoto; G Takada
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.